COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 775: Articles 7741-7750  | Next

Course and clinical severity of the SARS-CoV-2 Omicron variant infection in Tianjin, China
Ren, Y., Shi, L., Xie, Y., Wang, C., Zhang, W., Wang, F., Sun, H., Huang, L., Wu, Y., Xing, Z., Ren, W., Heinrich, J., Wu, Q., Zhengcun, P.
10.1101/2022.06.16.22271932 — Posted: 2022-06-16
Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands
van der Maaden, T., Mutubuki, E., de Bruijn, S., Leung, K. Y., Knoop, H., Slootweg, J., Tulen, A. D., Wong, A., van Hoek, A. J., Franz, E., van den Wijngaard, C. C.
10.1101/2022.06.15.22276439 — Posted: 2022-06-16
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
The OpenSAFELY Collaborative, , Parker, E. P., Tazare, J., Hulme, W. J., Bates, C., Beale, R., Carr, E. J., Cockburn, J., Curtis, H. J., Fisher, L., Green, A. C., Harper, S., Hester, F., Horne, E. M., Loud, F., Lyon, S., Mahalingasivam, V., Mehrkar, A., Nab, L., Parry, J., Santhakumaran, S., Steenkamp, R., Sterne, J. A., Walker, A. J., Williamson, E. J., Willicombe, M., Zheng, B., Goldacre, B., Nitsch, D., Tomlinson, L. A.
10.1101/2022.06.14.22276391 — Posted: 2022-06-16
Two-Step Machine Learning to Diagnose and Predict Involvement of Lungs in COVID-19 and Pneumonia using CT Radiomics
Moradi Khaniabadi, P., Bouchareb, Y., Al-Dhuhli, H., Shiri, I., Al-Kindi, F., Moradi Khaniabadi, B., Zaidi, H., Rahmim, A.
10.1101/2022.06.15.22276090 — Posted: 2022-06-16
A Systematic Review on COVID-19 Vaccine preferences using Discrete Choice Experiments
AMANI, A., SELENGUAI, H. K., PUEPI, Y. D., DAIROU, I. A., KENMOE, S., NOUKO, A., CHEUYEM, F. Z. L., NGO UM, S. S., KOKI, P. O. N., MBACHAM, W., ONGOLO-ZOGO, P.
10.1101/2022.06.12.22276299 — Posted: 2022-06-16
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
van Dorp, C. H., Goldberg, E. E., Hengartner, N., Ke, R., Romero-Severson, E. O.
10.1101/2022.06.15.22276436 — Posted: 2022-06-16
Effects of hydrometeorological and other factors on SARS-CoV-2 reproduction number in three contiguous countries of Tropical Andean South America: a spatiotemporally disaggregated time series analysis.
Colston, J. M., Hinson, P., Nguyen, N.-L. H., Chen, Y. T., Badr, H. S., Kerr, G. H., Gardner, L. M., Martin, D. N., Quispe, A. M., Schiaffino, F., Kosek, M. N., Zaitchik, B. F.
10.1101/2022.06.13.22276339 — Posted: 2022-06-16
Overt and occult hypoxemia in patients hospitalized with novel coronavirus disease 2019
Gadrey, S. M., Mohanty, P., Haughey, S. P., Jacobsen, B. A., Dubester, K. J., Webb, K. M., Kowalski, R. L., Dreicer, J. J., Andris, R. T., Clark, M. T., Moore, C. C., Holder, A., Kamaleswaran, R., Ratcliffe, S. J., Moorman, J. R.
10.1101/2022.06.14.22276166 — Posted: 2022-06-16
Titers and capacity of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: a single-blinded, randomized clinical trial
Chuang, C.-H., Huang, C.-G., Huang, C.-T., Chen, Y.-C., Kung, Y.-A., Chen, C.-J., Chuang, T.-C., Liu, C.-C., Huang, P.-W., Yang, S.-L., Gu, P.-W., Shih, S.-R., Chiu, C.-H.
10.1101/2022.06.14.22276236 — Posted: 2022-06-16
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.
Karampitsakos, T., Papaioannou, O., Tsiri, P., Katsaras, M., Katsimpris, A., Kalogeropoulos, A. P., Malakounidou, E., Zarkadi, E., Tsirikos, G., Georgiopoulou, V., Sotiropoulou, V., Koulousousa, E., Chourpiliadi, C., Matsioulas, A., Lagadinou, M., Sampsonas, F., Akinosoglou, K., Marangos, M., Tzouvelekis, A.
10.1101/2022.06.13.22276211 — Posted: 2022-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).